You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Moodys
Baxter
Mallinckrodt
McKesson

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

PILOCARPINE HYDROCHLORIDE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for pilocarpine hydrochloride and what is the scope of freedom to operate?

Pilocarpine hydrochloride is the generic ingredient in four branded drugs marketed by Alcon, Novartis, Akorn Inc, Somerset Theraps Llc, Aurobindo Pharma Ltd, Impax Labs, Innogenix, Lannett Co Inc, Perrigo Pharma Intl, and Concordia, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for pilocarpine hydrochloride. Fourteen suppliers are listed for this compound.

Recent Clinical Trials for PILOCARPINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidad de MurciaPhase 1
Montefiore Medical CenterPhase 3
Maastricht University Medical CenterEarly Phase 1

See all PILOCARPINE HYDROCHLORIDE clinical trials

Pharmacology for PILOCARPINE HYDROCHLORIDE

US Patents and Regulatory Information for PILOCARPINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride SOLUTION;OPHTHALMIC 204398-001 Sep 27, 2017 AT RX No No   Start Trial   Start Trial   Start Trial
Impax Labs PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 077248-001 Mar 31, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Akorn Inc PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride SOLUTION;OPHTHALMIC 204398-003 Sep 27, 2017 AT RX No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 077220-001 Oct 14, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Somerset Theraps Llc PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride SOLUTION;OPHTHALMIC 210384-003 Nov 25, 2019 AT RX No No   Start Trial   Start Trial   Start Trial
Concordia SALAGEN pilocarpine hydrochloride TABLET;ORAL 020237-001 Mar 22, 1994 AB RX Yes No   Start Trial   Start Trial   Start Trial
Novartis ISOPTO CARPINE pilocarpine hydrochloride SOLUTION;OPHTHALMIC 200890-001 Jun 22, 2010 AT RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Johnson and Johnson
AstraZeneca
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.